A detailed history of Trexquant Investment LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 513,097 shares of PCRX stock, worth $9.74 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
513,097
Previous 166,972 207.3%
Holding current value
$9.74 Million
Previous $4.78 Million 61.75%
% of portfolio
0.1%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$11.7 - $28.46 $4.05 Million - $9.85 Million
346,125 Added 207.3%
513,097 $7.73 Million
Q2 2024

Aug 13, 2024

BUY
$25.5 - $31.51 $3.65 Million - $4.5 Million
142,968 Added 595.6%
166,972 $4.78 Million
Q1 2024

May 14, 2024

BUY
$27.7 - $35.48 $664,910 - $851,661
24,004 New
24,004 $701,000
Q3 2023

Nov 13, 2023

BUY
$30.68 - $40.09 $486,124 - $635,226
15,845 New
15,845 $486,000
Q1 2023

May 15, 2023

SELL
$35.53 - $43.38 $503,886 - $615,215
-14,182 Reduced 33.73%
27,863 $1.14 Million
Q4 2022

Feb 13, 2023

BUY
$38.19 - $57.45 $1.61 Million - $2.42 Million
42,045 New
42,045 $1.62 Million
Q2 2022

Aug 11, 2022

BUY
$51.49 - $81.64 $240,046 - $380,605
4,662 New
4,662 $272,000
Q1 2020

May 08, 2020

SELL
$28.4 - $50.7 $128,737 - $229,823
-4,533 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$36.31 - $46.83 $164,593 - $212,280
4,533 New
4,533 $205,000
Q3 2019

Nov 08, 2019

SELL
$35.66 - $44.99 $980,721 - $1.24 Million
-27,502 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$36.57 - $47.97 $513,259 - $673,258
14,035 Added 104.22%
27,502 $1.2 Million
Q1 2019

May 13, 2019

SELL
$36.47 - $42.17 $438,697 - $507,262
-12,029 Reduced 47.18%
13,467 $513,000
Q4 2018

Feb 13, 2019

BUY
$41.31 - $52.16 $626,714 - $791,319
15,171 Added 146.93%
25,496 $1.1 Million
Q3 2018

Nov 09, 2018

SELL
$32.85 - $52.0 $999,954 - $1.58 Million
-30,440 Reduced 74.67%
10,325 $507,000
Q2 2018

Aug 07, 2018

BUY
$27.5 - $39.8 $1.12 Million - $1.62 Million
40,765 New
40,765 $1.31 Million
Q1 2018

May 03, 2018

SELL
$29.98 - $46.35 $427,095 - $660,302
-14,246 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$31.85 - $46.95 $275,884 - $406,680
8,662 Added 155.12%
14,246 $650,000
Q3 2017

Nov 09, 2017

BUY
$35.7 - $39.5 $199,348 - $220,568
5,584
5,584 $210,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $870M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.